search
Aptadir
Trends
- 1Italian biotech Aptadir raises €40M seed round for RNA inhibitors●Italian newco Aptadir raises €40M seed round for RNA inhibitors
Aptadir, a newly formed Italian biotech company, has raised a €40 million seed round to develop RNA inhibitors. The funding marks one of the larger seed rounds for an Italian life sciences startup and will support early-stage development of the company's RNA-targeting therapeutic platform as it builds out its research operations.